Genmab A/S (GMAB)
27.72
-1.00
(-3.48%)
USD |
NASDAQ |
May 02, 16:00
27.72
0.00 (0.00%)
After-Hours: 20:00
Genmab 1 Year Total Returns (Daily): -29.71% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 01, 2024 | -29.71% |
| April 30, 2024 | -32.48% |
| April 29, 2024 | -30.33% |
| April 26, 2024 | -31.07% |
| April 25, 2024 | -33.20% |
| April 24, 2024 | -31.48% |
| April 23, 2024 | -30.32% |
| April 22, 2024 | -29.32% |
| April 19, 2024 | -29.24% |
| April 18, 2024 | -32.01% |
| April 17, 2024 | -33.56% |
| April 16, 2024 | -29.22% |
| April 15, 2024 | -29.03% |
| April 12, 2024 | -25.20% |
| April 11, 2024 | -23.74% |
| April 10, 2024 | -22.89% |
| April 09, 2024 | -22.92% |
| April 08, 2024 | -23.20% |
| April 05, 2024 | -22.26% |
| April 04, 2024 | -20.98% |
| April 03, 2024 | -21.99% |
| April 02, 2024 | -20.66% |
| April 01, 2024 | -19.84% |
| March 28, 2024 | -19.42% |
| March 27, 2024 | -18.88% |
| Date | Value |
|---|---|
| March 26, 2024 | -17.48% |
| March 25, 2024 | -19.75% |
| March 22, 2024 | -17.48% |
| March 21, 2024 | -19.61% |
| March 20, 2024 | -18.13% |
| March 19, 2024 | -17.32% |
| March 18, 2024 | -17.18% |
| March 15, 2024 | -16.16% |
| March 14, 2024 | -15.90% |
| March 13, 2024 | -13.02% |
| March 12, 2024 | -9.89% |
| March 11, 2024 | -9.17% |
| March 08, 2024 | -13.70% |
| March 07, 2024 | -17.80% |
| March 06, 2024 | -20.84% |
| March 05, 2024 | -21.66% |
| March 04, 2024 | -22.32% |
| March 01, 2024 | -20.82% |
| February 29, 2024 | -26.06% |
| February 28, 2024 | -26.33% |
| February 27, 2024 | -23.29% |
| February 26, 2024 | -21.45% |
| February 23, 2024 | -21.99% |
| February 22, 2024 | -23.35% |
| February 21, 2024 | -26.26% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-39.80%
Minimum
Jun 16 2022
101.5%
Maximum
Jul 22 2020
20.63%
Average
16.98%
Median
1 Year Total Returns (Daily) Benchmarks
| Ascendis Pharma A/S | 62.46% |
| Novo Nordisk A/S | 56.22% |
| Galecto Inc | -59.99% |
| Evaxion Biotech AS | -69.21% |
| IO Biotech Inc | -17.56% |